カテゴリー： 世界, 部品/材料, Inkwood Research

ボツリヌス毒素のグローバル市場2023〜2032

【英語タイトル】GLOBAL BOTULINUM TOXIN MARKET FORECAST 2023-2032

Inkwood Researchが出版した調査資料（INK23JUL004）・商品コード：INK23JUL004
・発行会社（調査会社）：Inkwood Research
・発行日：2023年5月8日
   最新版(2025年又は2026年)はお問い合わせください。
・ページ数：233
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：化学
◆販売価格オプション（消費税別）
Single UserUSD2,500 ⇒換算￥390,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算￥468,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算￥702,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Inkwood Research社の本調査レポートによると、ボツリヌス毒素の世界市場が2023年〜2032年にかけて年平均10.07%で拡大すると見込まれています。本書は、ボツリヌス毒素の世界市場について調査し、市場状況や今後の展望を整理しています。調査範囲・調査手法、エグゼクティブサマリー、市場動向、主要分析、種類別（A型ボツリヌス毒素、B型ボツリヌス毒素）分析、使用人口統計別（女性、男性）分析、用途別（医療用、美容用）分析、エンドユーザー別（専門＆皮膚科医院、病院・診療所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ、アメリカ、カナダ、イギリス、ドイツ、フランス、イタリア、スペイン、中国、日本、インド、韓国、シンガポール、その他地域）分析、競争状況などの項目が掲載されています。また、市場参入企業として、ABBVIE、CANDELA MEDICAL、DAEWOONG PHARMACEUTICAL CO LTD、EVOLUS INC、GALDERMA、HUGEL INC、IPSENなどの情報が含まれています。
・調査範囲・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・世界のボツリヌス毒素市場規模：種類別
- A型ボツリヌス毒素の市場規模
- B型ボツリヌス毒素の市場規模
・世界のボツリヌス毒素市場規模：使用人口統計別
- 女性における市場規模
- 男性における市場規模
・世界のボツリヌス毒素市場規模：用途別
- 医療用ボツリヌス毒素の市場規模
- 美容用ボツリヌス毒素の市場規模
・世界のボツリヌス毒素市場規模：エンドユーザー別
- 専門＆皮膚科医院における市場規模
- 病院・診療所における市場規模
- その他エンドユーザーにおける市場規模
・世界のボツリヌス毒素市場規模：地域別
- 北米のボツリヌス毒素市場規模
- ヨーロッパのボツリヌス毒素市場規模
- アジア太平洋のボツリヌス毒素市場規模
- 中南米のボツリヌス毒素市場規模
- 中東/アフリカのボツリヌス毒素市場規模
- アメリカのボツリヌス毒素市場規模
- カナダのボツリヌス毒素市場規模
- イギリスのボツリヌス毒素市場規模
- ドイツのボツリヌス毒素市場規模
- フランスのボツリヌス毒素市場規模
- イタリアのボツリヌス毒素市場規模
- スペインのボツリヌス毒素市場規模
- 中国のボツリヌス毒素市場規模
- 日本のボツリヌス毒素市場規模
- インドのボツリヌス毒素市場規模
- 韓国のボツリヌス毒素市場規模
- シンガポールのボツリヌス毒素市場規模
- その他地域のボツリヌス毒素市場規模
・競争状況

KEY FINDINGS
The global botulinum toxin market is predicted to record a 10.07% CAGR during the forecast period, 2023-2032. The surge in demand for aesthetic procedures, the rising geriatric population, and the demand for non-invasive cosmetic procedures driving the botulinum toxin market drive the market growth.

MARKET INSIGHTS
Botulinum toxin is a neurotoxin produced by certain Clostridium botulinum strains and is utilized for both therapeutic and cosmetic purposes. Its cosmetic form, commonly referred to as Botox by patients, is an injectable that temporarily reduces or eliminates wrinkles and fine lines on the face. The most frequently treated areas include frown lines, forehead wrinkles, and crow’s feet around the eyes, but it is also used to treat other areas such as gummy smiles, lip lines, overactive jaw muscles, and thick neck bands.
Several factors, including increasing demand for aesthetic procedures, growth in non-invasive cosmetic procedures, research and development initiatives, and a rise in the geriatric population, are propelling the global market for botulinum toxin. With an increasing number of people worldwide undergoing aesthetic procedures each year, the market for botulinum toxin is expected to experience significant growth in the coming years.

REGIONAL INSIGHTS
The global botulinum toxin market analysis comprises a study of Europe, Asia-Pacific, North America, and Rest of World. North America is expected to dominate the market due to the growing R&D efforts to broaden therapeutic uses and an increase in cosmetic issues like crow’s feet and medial canthal wrinkles. Additionally, factors such as disposable personal income and per capita disposable income in the United States are expected to fuel the growth of the botulinum toxin market in North America.

COMPETITIVE INSIGHTS
Market players invest in R&D, label extension, and acquisitions to enhance product offerings. Innovation, advertising, competitive strategies, and high concentration ratio increase industry rivalry.
Major market players include Medytox, Merz Pharma, Lanzhou Institute of Biological Products Co Ltd, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. FAVORABLE REGULATORY APPROVALS ADD TO MARKET GROWTH
2.5.2. GROWING AWARENESS ABOUT ‘NOTOX’
2.5.3. INFLATING COSMETIC TOURISM ADDS TO THE DEMAND FOR BOTULINUM TOXIN
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGE IN DEMAND FOR AESTHETIC PROCEDURES
3.1.2. RISING GERIATRIC POPULATION
3.1.3. GROWING DEMAND FOR NON-INVASIVE COSMETIC PROCEDURES
3.2. KEY RESTRAINTS
3.2.1. CONCERNS REGARDING THE ADVERSE EFFECTS OF BOTULINUM TOXIN
3.2.2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.3.2. GROWTH PROSPECT MAPPING FOR GERMANY
4.3.3. GROWTH PROSPECT MAPPING FOR CHINA
4.3.4. GROWTH PROSPECT MAPPING FOR BRAZIL
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
5. MARKET BY TYPE
5.1. TYPE A BOTULINUM TOXIN
5.2. TYPE B BOTULINUM TOXIN
6. MARKET BY USER DEMOGRAPHIC
6.1. WOMEN
6.2. MEN
7. MARKET BY APPLICATION
7.1. MEDICAL
7.1.1. CHRONIC MIGRAINE
7.1.2. MUSCLE SPASM
7.1.3. OVERACTIVE BLADDER
7.1.4. HYPERHIDROSIS
7.1.5. OTHER MEDICAL APPLICATIONS
7.2. AESTHETIC
7.2.1. CROW’S FEET
7.2.2. FOREHEAD LINES
7.2.3. FROWN LINES/GLABELLAR
7.2.4. SQUARE JAW/MASSETER
7.2.5. OTHER AESTHETIC APPLICATIONS
8. MARKET BY END-USER
8.1. SPECIALTY AND DERMATOLOGY CLINICS
8.2. HOSPITALS AND CLINICS
8.3. OTHER END-USERS
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. MARKET SIZE & ESTIMATES
9.1.2. NORTH AMERICA BOTULINUM TOXIN MARKET DRIVERS
9.1.3. NORTH AMERICA BOTULINUM TOXIN MARKET CHALLENGES
9.1.4. NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
9.1.5. KEY PLAYERS IN NORTH AMERICA BOTULINUM TOXIN MARKET
9.1.6. COUNTRY ANALYSIS
9.1.6.1. UNITED STATES
9.1.6.1.1. UNITED STATES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.1.6.2. CANADA
9.1.6.2.1. CANADA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2. EUROPE
9.2.1. MARKET SIZE & ESTIMATES
9.2.2. EUROPE BOTULINUM TOXIN MARKET DRIVERS
9.2.3. EUROPE BOTULINUM TOXIN MARKET CHALLENGES
9.2.4. EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
9.2.5. KEY PLAYERS IN EUROPE BOTULINUM TOXIN MARKET
9.2.6. COUNTRY ANALYSIS
9.2.6.1. UNITED KINGDOM
9.2.6.1.1. UNITED KINGDOM BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.2. GERMANY
9.2.6.2.1. GERMANY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.3. FRANCE
9.2.6.3.1. FRANCE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.4. ITALY
9.2.6.4.1. ITALY BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.5. SPAIN
9.2.6.5.1. SPAIN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.6. NORDIC COUNTRIES
9.2.6.6.1. NORDIC COUNTRIES BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.7. POLAND
9.2.6.7.1. POLAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.2.6.8. REST OF EUROPE
9.2.6.8.1. REST OF EUROPE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3. ASIA-PACIFIC
9.3.1. MARKET SIZE & ESTIMATES
9.3.2. ASIA-PACIFIC BOTULINUM TOXIN MARKET DRIVERS
9.3.3. ASIA-PACIFIC BOTULINUM TOXIN MARKET CHALLENGES
9.3.4. ASIA-PACIFIC BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
9.3.5. KEY PLAYERS IN ASIA-PACIFIC BOTULINUM TOXIN MARKET
9.3.6. COUNTRY ANALYSIS
9.3.6.1. CHINA
9.3.6.1.1. CHINA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.2. JAPAN
9.3.6.2.1. JAPAN BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.3. INDIA
9.3.6.3.1. INDIA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.4. SOUTH KOREA
9.3.6.4.1. SOUTH KOREA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.5. SINGAPORE
9.3.6.5.1. SINGAPORE BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.6. THAILAND
9.3.6.6.1. THAILAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.7. AUSTRALIA & NEW ZEALAND
9.3.6.7.1. AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.3.6.8. REST OF ASIA-PACIFIC
9.3.6.8.1. REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.4. REST OF WORLD
9.4.1. MARKET SIZE & ESTIMATES
9.4.2. REST OF WORLD BOTULINUM TOXIN MARKET DRIVERS
9.4.3. REST OF WORLD BOTULINUM TOXIN MARKET CHALLENGES
9.4.4. REST OF WORLD BOTULINUM TOXIN REGULATORY FRAMEWORK
9.4.5. KEY PLAYERS IN REST OF WORLD BOTULINUM TOXIN MARKET
9.4.6. REGIONAL ANALYSIS
9.4.6.1. LATIN AMERICA
9.4.6.1.1. LATIN AMERICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
9.4.6.2. MIDDLE EAST & AFRICA
9.4.6.2.1. MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET SIZE & OPPORTUNITIES
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS
10.1.4. BUSINESS EXPANSIONS
10.2. COMPANY PROFILES
10.2.1. ABBVIE
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCT LIST
10.2.1.3. STRENGTHS & CHALLENGES
10.2.2. CANDELA MEDICAL
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCT LIST
10.2.2.3. STRENGTHS & CHALLENGES
10.2.3. DAEWOONG PHARMACEUTICAL CO LTD
10.2.3.1. COMPANY PROFILE
10.2.3.2. PRODUCT LIST
10.2.3.3. STRENGTHS & CHALLENGES
10.2.4. EVOLUS INC
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCT LIST
10.2.4.3. STRENGTHS & CHALLENGES
10.2.5. GALDERMA
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCT LIST
10.2.5.3. STRENGTHS & CHALLENGES
10.2.6. HUGEL INC
10.2.6.1. COMPANY OVERVIEW
10.2.6.2. PRODUCT LIST
10.2.6.3. STRENGTHS & CHALLENGES
10.2.7. IPSEN
10.2.7.1. COMPANY OVERVIEW
10.2.7.2. PRODUCTS / SERVICES LIST
10.2.7.3. STRENGTHS & CHALLENGES
10.2.8. LANZHOU INSTITUTE OF BIOLOGICAL PRODUCTS CO LTD
10.2.8.1. COMPANY OVERVIEW
10.2.8.2. PRODUCT LIST
10.2.8.3. STRENGTHS & CHALLENGES
10.2.9. MEDYTOX INC
10.2.9.1. COMPANY OVERVIEW
10.2.9.2. PRODUCT LIST
10.2.9.3. STRENGTHS & CHALLENGES
10.2.10. MERZ PHARMA
10.2.10.1. COMPANY OVERVIEW
10.2.10.2. PRODUCT LIST
10.2.10.3. STRENGTHS & CHALLENGES
10.2.11. REVANCE THERAPEUTICS INC
10.2.11.1. COMPANY OVERVIEW
10.2.11.2. PRODUCT LIST
10.2.12. US WORLDMEDS LLC
10.2.12.1. COMPANY OVERVIEW
10.2.12.2. PRODUCT LIST

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – BOTULINUM TOXIN
TABLE 2: EXAMPLE OF COMMERCIALLY AVAILABLE BOTULINUM TOXIN TYPE A FOR AESTHETIC PROCEDURES
TABLE 3: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 5: GLOBAL TYPE A BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: GLOBAL TYPE A BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 7: GLOBAL TYPE B BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: GLOBAL TYPE B BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 9: GLOBAL BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: GLOBAL BOTULINUM TOXIN MARKET, BY USER DEMOGRAPHIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 11: GLOBAL WOMEN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: GLOBAL WOMEN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 13: GLOBAL MEN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 14: GLOBAL MEN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 15: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 16: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 17: GLOBAL MEDICAL MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 18: GLOBAL MEDICAL MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 19: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 20: GLOBAL BOTULINUM TOXIN MARKET, BY MEDICAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 21: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 22: GLOBAL CHRONIC MIGRAINE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 23: GLOBAL MUSCLE SPASM MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 24: GLOBAL MUSCLE SPASM MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 25: GLOBAL OVERACTIVE BLADDER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 26: GLOBAL OVERACTIVE BLADDER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 27: GLOBAL HYPERHIDROSIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 28: GLOBAL HYPERHIDROSIS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 29: GLOBAL OTHER MEDICAL APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 30: GLOBAL OTHER MEDICAL APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 31: GLOBAL AESTHETIC MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 32: GLOBAL AESTHETIC MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 33: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 34: GLOBAL BOTULINUM TOXIN MARKET, BY AESTHETIC, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 35: GLOBAL CROW’S FEET MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 36: GLOBAL CROW’S FEET MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 37: GLOBAL FOREHEAD LINES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 38: GLOBAL FOREHEAD LINES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 39: GLOBAL FROWN LINES/GLABELLAR MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 40: GLOBAL FROWN LINES/GLABELLAR MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 41: GLOBAL SQUARE JAW/MASSETER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 42: GLOBAL SQUARE JAW/MASSETER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 43: GLOBAL OTHER AESTHETIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 44: GLOBAL OTHER AESTHETIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 45: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 46: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 47: GLOBAL SPECIALTY AND DERMATOLOGY CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 48: GLOBAL SPECIALTY AND DERMATOLOGY CLINICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 49: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 50: GLOBAL HOSPITALS AND CLINICS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 51: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 52: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 53: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 54: GLOBAL BOTULINUM TOXIN MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 55: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 56: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 57: NORTH AMERICA BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 58: KEY PLAYERS OPERATING IN NORTH AMERICA BOTULINUM TOXIN MARKET
TABLE 59: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 60: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 61: EUROPE BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 62: KEY PLAYERS OPERATING IN EUROPE BOTULINUM TOXIN MARKET
TABLE 63: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 64: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 65: ASIA-PACIFIC BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 66: KEY PLAYERS OPERATING IN ASIA-PACIFIC BOTULINUM TOXIN MARKET
TABLE 67: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 68: REST OF WORLD BOTULINUM TOXIN MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 69: REST OF WORLD BOTULINUM TOXIN MARKET REGULATORY FRAMEWORK
TABLE 70: KEY PLAYERS OPERATING IN REST OF WORLD BOTULINUM TOXIN MARKET
TABLE 71: LIST OF ACQUISITIONS
TABLE 72: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 73: LIST OF PARTNERSHIPS
TABLE 74: LIST OF BUSINESS EXPANSIONS

※参考情報

ボツリヌス毒素は、細菌の一種であるボツリヌス菌（Clostridium botulinum）が産生する神経毒です。この毒素は、最も強力な毒素の一つとされ、非常に少量でも人間に深刻な影響を与えることがあり、特に筋肉の麻痺を引き起こすことで知られています。ボツリヌス毒素は、主に食中毒や呼吸器の合併症を引き起こす原因となります。

ボツリヌス毒素には7つの主要な型があり、これらはA、B、C、D、E、F、Gと分類されます。特にA型とB型が人間に対して重要であり、多くの食中毒事件や医療応用に関与しています。A型は最も毒性が強く、B型も広く知られています。その他の型は主に動物に影響を及ぼすことが多く、特に家畜や野生動物において問題を引き起こすことがあります。

ボツリヌス毒素は、その毒性のために医療においても多くの利用方法があります。代表的な使用例としては、ボトックスと呼ばれる美容目的での注射があります。ボトックスは、筋肉の活動を一時的に抑えることにより、しわを減少させる効果があります。この治療法は、特に表情じわや額のしわに対して効果的です。

また、医療の分野では、筋肉の過活動を抑制するためにボツリヌス毒素が利用されることもあります。たとえば、重度の痙攣性疾患や偏頭痛の治療において、毒素が筋肉に注射されることで、症状の緩和が期待できます。また、脳卒中後のリハビリテーションにおいても、痙縮を軽減するために使用されることがあります。

ボツリヌス毒素の効果を最大限に活用するためには、関連技術も重要です。調整された温度やpHでの保存や、適切な投与方法が、その効果を左右します。毒素は微生物によって産生されるため、適切な培養技術も必要です。コールドチェーン管理や無菌条件下での取り扱いが、毒素の安定性を維持するために重要です。

ボツリヌス毒素を利用した技術の一例として、細胞内に選択的に導入される遺伝子治療があります。新しいアプローチとして、毒素を用いたがん治療に関する研究も進められています。特定のがん細胞を標的にし、毒素を利用して細胞死を誘導することが期待されています。この分野はまだ研究段階ですが、急速に進展しています。

さらに、ボツリヌス毒素の生成に関する研究も進んでおり、その生産効率を高めるための新しい方法が模索されています。微生物工学や合成生物学の技術を活用し、より安定した毒素の生産や、毒素の特性を変える試みが行われています。これにより、医療分野における利用がさらに広がることが期待されます。

ボツリヌス毒素には、食中毒という厄介な側面と、医療技術としての利点が共存しています。その特性を理解し、適切に管理することが重要です。今後、ボツリヌス毒素を利用した新しい治療法や技術が発展することで、人々の健康に寄与する可能性が高まると考えられます。


★調査レポート[ボツリヌス毒素のグローバル市場2023〜2032] (コード：INK23JUL004)販売に関する免責事項を必ずご確認ください。
★調査レポート[ボツリヌス毒素のグローバル市場2023〜2032]についてメールでお問い合わせ

※関連調査レポートはありません。


◆H&Iグローバルリサーチのお客様（例）◆